Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Physicians & Staff

Marci Drees, M.D., MS, DTMH, FACP, FSHEA

Infection Prevention Officer and Hospital Epidemiologist

Marci Drees, M.D., MS, DTMH, FACP, FSHEA, is the Chief Infection Prevention Officer and hospital epidemiologist for ChristianaCare. Dr. Drees graduated from the University of Chicago Pritzker School of Medicine in 1998. She was a resident in internal medicine at the University of Colorado Health Sciences Center in Denver. She also completed a diploma of tropical medicine and hygiene at the London School of Hygiene and Tropical Medicine in England.

Her work in public health and epidemiology began in 2002, when she became an officer in the Epidemic Intelligence Service for the Centers for Disease Control and Prevention. During this two-year training program, she was stationed with the Delaware Division of Public Health in Dover. She spent the next three years at Tufts Medical Center in Boston, where she completed two fellowships. One was in geographic medicine and infectious diseases. The other was in clinical care research at the Institute for Clinical Research and Health Policy Studies, Sackler School of Graduate Biomedical Sciences at Tufts University, during which she earned a master’s degree in clinical research.

Dr. Drees joined ChristianaCare in 2007. Her other roles in the health system include providing care for patients living with HIV and/or hepatitis C the for the William J. Holloway Community Program. She serves as chair of the Infection Prevention Committee. Dr. Drees also serves on the Healthcare-Associated Infections Advisory Committee for the Delaware Division of Public Health and the Delaware Immunization Coalition.

Her clinical research has covered topics such as infant mortality, flu vaccination, outpatient antibiotic use, healthcare-associated infections and disease outbreaks.

Dr. Drees also is an associate professor in the Department of Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia and an adjunct assistant professor at Tufts University School of Medicine in Boston.

Dr. Drees is a fellow in the American College of Physicians and of the Society of Healthcare Epidemiology of America. She is currently SHEA’s liaison to the CDC’s Advisory Committee on Immunization Practice (ACIP) and beginning in 2021, will be the chair of SHEA’s Education Committee. She is board certified in internal medicine and infectious diseases.

Specialties: Infectious Disease
Internal Medicine
Contact:

John H. Ammon Medical Education Center
Suite 2E70
4755 Ogletown-Stanton Road
Newark, DE 19713
302-733-5602
302-733-6386 Fax

Residency: University of Colorado Health Sciences Center
Fellowship: New England Medical Center Hospital